NO170853C - Analogifremgangsmaate for fremstilling av terapeutisk aktive 4-fosfonoalkenylpiperidin-2-karboksylsyrer - Google Patents
Analogifremgangsmaate for fremstilling av terapeutisk aktive 4-fosfonoalkenylpiperidin-2-karboksylsyrerInfo
- Publication number
- NO170853C NO170853C NO874854A NO874854A NO170853C NO 170853 C NO170853 C NO 170853C NO 874854 A NO874854 A NO 874854A NO 874854 A NO874854 A NO 874854A NO 170853 C NO170853 C NO 170853C
- Authority
- NO
- Norway
- Prior art keywords
- carboxyl
- phosphonoalkenyl
- piperidine
- preparation
- carbon
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/08—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
- C07D211/10—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with radicals containing only carbon and hydrogen atoms attached to ring carbon atoms
- C07D211/12—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with radicals containing only carbon and hydrogen atoms attached to ring carbon atoms with only hydrogen atoms attached to the ring nitrogen atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
- C07F9/553—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having one nitrogen atom as the only ring hetero atom
- C07F9/576—Six-membered rings
- C07F9/60—Quinoline or hydrogenated quinoline ring systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
- C07F9/553—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having one nitrogen atom as the only ring hetero atom
- C07F9/572—Five-membered rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
- C07F9/553—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having one nitrogen atom as the only ring hetero atom
- C07F9/576—Six-membered rings
- C07F9/59—Hydrogenated pyridine rings
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- Anesthesiology (AREA)
- Pain & Pain Management (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Steroid Compounds (AREA)
- Quinoline Compounds (AREA)
- Hydrogenated Pyridines (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Dental Preparations (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US93370286A | 1986-11-21 | 1986-11-21 |
Publications (4)
| Publication Number | Publication Date |
|---|---|
| NO874854D0 NO874854D0 (no) | 1987-11-20 |
| NO874854L NO874854L (no) | 1988-05-24 |
| NO170853B NO170853B (no) | 1992-09-07 |
| NO170853C true NO170853C (no) | 1992-12-16 |
Family
ID=25464377
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO874854A NO170853C (no) | 1986-11-21 | 1987-11-20 | Analogifremgangsmaate for fremstilling av terapeutisk aktive 4-fosfonoalkenylpiperidin-2-karboksylsyrer |
Country Status (21)
| Country | Link |
|---|---|
| EP (1) | EP0275820B1 (da) |
| JP (1) | JPH0686470B2 (da) |
| KR (1) | KR880006195A (da) |
| AT (1) | ATE60776T1 (da) |
| AU (1) | AU610841B2 (da) |
| CA (1) | CA1312608C (da) |
| DD (1) | DD273837A5 (da) |
| DE (1) | DE3768000D1 (da) |
| DK (1) | DK609487A (da) |
| ES (1) | ES2031927T3 (da) |
| FI (1) | FI86638C (da) |
| GR (1) | GR3001443T3 (da) |
| HU (1) | HU199857B (da) |
| IE (1) | IE60534B1 (da) |
| IL (1) | IL84492A0 (da) |
| MX (1) | MX9437A (da) |
| NO (1) | NO170853C (da) |
| NZ (1) | NZ222607A (da) |
| PH (1) | PH25465A (da) |
| PT (1) | PT86168B (da) |
| ZA (1) | ZA878699B (da) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4968678A (en) * | 1988-02-19 | 1990-11-06 | Eli Lilly And Company | Tetrazole excitatory amino acid receptor antagonists |
| CA2000901A1 (en) * | 1988-10-21 | 1990-04-21 | Alexis A. Cordi | Phosphono-hydroisoquinoline compounds useful in reducing neurotoxic injury |
| US4902695A (en) * | 1989-02-13 | 1990-02-20 | Eli Lilly And Company | Excitatory amino acid receptor antagonists |
| EP0424179A3 (en) * | 1989-10-20 | 1991-12-27 | John William Olney | Use of combined excitatory amino acid and cholinergic antagonists to prevent neurological deterioration |
| US5238958A (en) * | 1990-02-26 | 1993-08-24 | Warner-Lambert Company | Substituted α-amino acids having selected acidic moieties for use as excitatory amino acid antagonists in pharmaceuticals |
| US5194430A (en) * | 1990-05-17 | 1993-03-16 | Merrell Dow Pharmaceuticals Inc. | Heterocyclic-nmda antagonists |
| SE9003652D0 (sv) * | 1990-11-15 | 1990-11-15 | Astra Ab | New heterocyclic compounds |
| US5260286A (en) * | 1992-10-16 | 1993-11-09 | Japan Tobacco, Inc. | 2-piperidinecarboxylic acid derivatives useful as NMDA receptor antagonists |
| DE69835518T2 (de) | 1997-06-12 | 2007-08-09 | Aventis Pharma Ltd., West Malling | Imidazolyl-cyclische acetale |
| EP3427729A1 (en) | 2017-07-13 | 2019-01-16 | Paris Sciences et Lettres - Quartier Latin | Probenecid for use in treating epileptic diseases, disorders or conditions |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB2104079B (en) * | 1981-08-14 | 1985-08-21 | London Polytech | New aminoacid isomers, their production and their medicinal use |
| PH23848A (en) * | 1985-05-24 | 1989-11-23 | Ciba Geigy Ag | Certain phosphonic acids and derivatives |
-
1987
- 1987-11-16 DE DE8787810662T patent/DE3768000D1/de not_active Expired - Lifetime
- 1987-11-16 ES ES198787810662T patent/ES2031927T3/es not_active Expired - Lifetime
- 1987-11-16 AT AT87810662T patent/ATE60776T1/de active
- 1987-11-16 IL IL84492A patent/IL84492A0/xx unknown
- 1987-11-16 EP EP87810662A patent/EP0275820B1/de not_active Expired - Lifetime
- 1987-11-18 PH PH36083A patent/PH25465A/en unknown
- 1987-11-18 FI FI875097A patent/FI86638C/fi not_active IP Right Cessation
- 1987-11-19 PT PT86168A patent/PT86168B/pt not_active IP Right Cessation
- 1987-11-19 CA CA000552204A patent/CA1312608C/en not_active Expired - Fee Related
- 1987-11-19 NZ NZ222607A patent/NZ222607A/xx unknown
- 1987-11-19 DD DD87309215A patent/DD273837A5/de not_active IP Right Cessation
- 1987-11-20 KR KR870013064A patent/KR880006195A/ko not_active Withdrawn
- 1987-11-20 NO NO874854A patent/NO170853C/no unknown
- 1987-11-20 IE IE314987A patent/IE60534B1/en not_active IP Right Cessation
- 1987-11-20 HU HU875161A patent/HU199857B/hu not_active IP Right Cessation
- 1987-11-20 JP JP62292195A patent/JPH0686470B2/ja not_active Expired - Lifetime
- 1987-11-20 AU AU81455/87A patent/AU610841B2/en not_active Ceased
- 1987-11-20 ZA ZA878699A patent/ZA878699B/xx unknown
- 1987-11-20 DK DK609487A patent/DK609487A/da not_active Application Discontinuation
- 1987-11-23 MX MX943787A patent/MX9437A/es unknown
-
1991
- 1991-02-07 GR GR90401113T patent/GR3001443T3/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| PT86168A (en) | 1987-12-01 |
| JPH0686470B2 (ja) | 1994-11-02 |
| DK609487A (da) | 1988-05-22 |
| PT86168B (pt) | 1990-08-31 |
| DK609487D0 (da) | 1987-11-20 |
| NO874854L (no) | 1988-05-24 |
| NZ222607A (en) | 1990-10-26 |
| GR3001443T3 (en) | 1992-09-25 |
| FI875097A0 (fi) | 1987-11-18 |
| DD273837A5 (de) | 1989-11-29 |
| IL84492A0 (en) | 1988-04-29 |
| CA1312608C (en) | 1993-01-12 |
| HUT46331A (en) | 1988-10-28 |
| PH25465A (en) | 1991-07-01 |
| IE873149L (en) | 1988-05-21 |
| EP0275820B1 (de) | 1991-02-06 |
| FI875097A7 (fi) | 1988-05-22 |
| EP0275820A3 (en) | 1988-08-03 |
| HU199857B (en) | 1990-03-28 |
| FI86638B (fi) | 1992-06-15 |
| NO170853B (no) | 1992-09-07 |
| DE3768000D1 (de) | 1991-03-14 |
| NO874854D0 (no) | 1987-11-20 |
| EP0275820A2 (de) | 1988-07-27 |
| AU8145587A (en) | 1988-05-26 |
| JPH01135791A (ja) | 1989-05-29 |
| KR880006195A (ko) | 1988-07-22 |
| ES2031927T3 (es) | 1993-01-01 |
| IE60534B1 (en) | 1994-07-27 |
| ZA878699B (en) | 1988-05-23 |
| ATE60776T1 (de) | 1991-02-15 |
| AU610841B2 (en) | 1991-05-30 |
| MX9437A (es) | 1994-01-31 |
| FI86638C (fi) | 1992-09-25 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO170807C (no) | Analogifremgangsmaate for fremstilling av fosfonsyrer og derivater derav | |
| NO170853C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive 4-fosfonoalkenylpiperidin-2-karboksylsyrer | |
| NO885438L (no) | Fremgangsmaate til fremstilling av optisk aktive 3-desmetylmevalonsyrederivater samt mellomprodukter. | |
| DK0384842T3 (da) | 19-nor-steroider substitueret i 11beta-stillingen med en carbonkæde med en amid- eller carbamatgruppe, deres fremstillingsmetode og mellemprodukter med denne fremstillingsmetode, deres anvendelse som lægemidler og farmaceutiske præparater med indhold deraf | |
| FI881892A0 (fi) | Menetelmä uusien, terapeuttisesti käyttökelpoisten 1,2,5,6-tetrahydropyridiinijohdannaisten valmistamiseksi | |
| FI871445A0 (fi) | Foerfarande foer framstaellning av nya spergualinderivat. | |
| KR880001653A (ko) | 신규의 치환된 피리도[2,3-b][1,4]벤조디아제핀-6-온, 이의 제조방법 및 이를 함유하는 약제 | |
| FI873327A0 (fi) | Nya 3-aryl-3-cykloalkyl-piperidin -2,6-dionderivat. | |
| ES2076369T3 (es) | Procedimiento para la separacion de racematos de esteres de acidos 4-aril-2-oxo-pirrolidina-3-carboxilicos. | |
| ES2053868T3 (es) | 3-aminosidnoniminas substituidas, procedimientos para su obtencion y su empleo. | |
| DK161090A (da) | Nyt topikalt praeparat til behandling af alopeci | |
| ES2038389T3 (es) | Procedimiento para la obtencion de 3-aminosidnoniminas substituidas farmacologicamente activas. |